News
News releases on October 22, 2023
Every news release public companies put out on October 22, 2023 (UTC): 22 news releases, newest first. Open any release to read it.
Renounceable Rights Issue to advance WA project portfolio
Forrestania Resources Limited · Oct 22, 2023
Saudi National Bank is a strategic partner for the Seventh Future Investment Initiative
Saudi National Bank · Oct 22, 2023
Kissei Pharmaceutical: Results of Japanese Phase III Clinical Study of KORSUVA® IV Injection for Pruritus in Patients undergoing Hemodial...
Kissei Pharmaceutical Co., Ltd. · Oct 22, 2023
Beach Energy engages with community in Offshore Gas Victoria Project consultations
Beach Energy Limited · Oct 22, 2023
Disclosure on appointment of Senior Independent Director
Prime Lands Residencies PLC · Oct 22, 2023
Press Release Oct 22 2023
Rossari Biotech Ltd · Oct 22, 2023
Press Release (Revised) Oct 22 2023
Sportking India Ltd. · Oct 22, 2023
Press Release Oct 22 2023
Arvind SmartSpaces Ltd. · Oct 22, 2023
Press Release Oct 22 2023
Kotak Mahindra Bank Limited · Oct 22, 2023
Press Release Oct 22 2023
RBL Bank Ltd. · Oct 22, 2023
Updated Data from CIRCULATE-Japan Presented at ESMO 2023 Reinforces Signatera’s Prognostic and Predictive Value in Analysis of 2,500+ Col...
Natera, Inc. · Oct 22, 2023
Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial ...
Sutro Biopharma, Inc. · Oct 22, 2023
Scripps Howard Fund announces winners of 70th Scripps Howard Awards
E.W. Scripps Company · Oct 22, 2023
Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236
Revolution Medicines, Inc. · Oct 22, 2023
Potential of Arvinas’ PROTAC® AR Degraders Reinforced by 11.1 months rPFS with Bavdegalutamide and Updated Positive Interim Data from Sec...
Arvinas, Inc. · Oct 22, 2023
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
Olema Pharmaceuticals, Inc. · Oct 22, 2023
Marqeta Study: Even Satisfied Credit Cardholders Are Shopping For Their Next Card, Seeking Tailored Rewards and Embedded Finance Experiences
Marqeta, Inc. · Oct 22, 2023
Dupixent® (dupilumab) Phase 3 Results Show Sustained Efficacy for Up to One Year in Children 1 to 11 Years of Age with Eosinophilic Esoph...
Regeneron Pharmaceuticals, Inc. · Oct 22, 2023
Detailed Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2023
Exelixis, Inc. · Oct 22, 2023
Cobre Panamá Mining Concession Contract Enacted Into Law in Panamá
First Quantum Minerals Ltd. · Oct 22, 2023
Amgen presents new LUMAKRAS® (sotorasib) plus Vectibix® (panitumumab) data in patients with KRAS G12C-mutated metastatic colorectal cancer
Amgen Inc. · Oct 22, 2023
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
Agenus Inc. · Oct 22, 2023